This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Acasti Pharma 미래 성장
Future 기준 확인 4/6
주요 정보
-28.1%
수익 성장률
-30.2%
EPS 성장률
| Pharmaceuticals 수익 성장 | 50.4% |
| 매출 성장률 | 26.1% |
| 향후 자기자본 수익률 | n/a |
| 애널리스트 커버리지 | Low |
| 마지막 업데이트 | 16 Feb 2023 |
수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 3/31/2025 | 97 | -38 | 27 | N/A | 3 |
| 3/31/2024 | 160 | 161 | 12 | -25 | 2 |
| 3/31/2023 | N/A | -6 | -17 | -17 | 2 |
| 12/31/2022 | N/A | -17 | -16 | -16 | N/A |
| 9/30/2022 | N/A | -17 | -17 | -17 | N/A |
| 6/30/2022 | N/A | -11 | -19 | -19 | N/A |
| 3/31/2022 | N/A | -10 | -17 | -17 | N/A |
| 12/31/2021 | 0 | -12 | -16 | -16 | N/A |
| 9/30/2021 | 0 | -11 | -15 | -15 | N/A |
| 6/30/2021 | 0 | -18 | -14 | -14 | N/A |
| 3/31/2021 | 0 | -20 | -14 | -14 | N/A |
| 12/31/2020 | 0 | 3 | -16 | -15 | N/A |
| 9/30/2020 | N/A | -6 | -19 | -18 | N/A |
| 6/30/2020 | N/A | -21 | -21 | -20 | N/A |
| 3/31/2020 | N/A | -26 | -23 | -23 | N/A |
| 12/31/2019 | N/A | -56 | -29 | -29 | N/A |
| 9/30/2019 | N/A | -46 | -29 | -29 | N/A |
| 6/30/2019 | N/A | -42 | -27 | -27 | N/A |
| 3/31/2019 | N/A | -39 | -25 | -25 | N/A |
| 12/31/2018 | N/A | -31 | -20 | -19 | N/A |
| 9/30/2018 | N/A | -34 | -17 | -16 | N/A |
| 6/30/2018 | N/A | -20 | -13 | -13 | N/A |
| 3/31/2018 | N/A | -17 | -10 | -10 | N/A |
| 3/31/2017 | N/A | -8 | -7 | -5 | N/A |
| 11/30/2016 | 0 | -7 | N/A | -5 | N/A |
| 8/31/2016 | 0 | -7 | N/A | -5 | N/A |
| 5/31/2016 | 0 | -6 | N/A | -6 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: ACST's earnings are forecast to decline over the next 3 years (-28.1% per year).
수익 vs 시장: ACST is forecast to become profitable over the next 3 years, which is considered above average market growth.
고성장 수익: ACST is expected to become profitable in the next 3 years.
수익 대 시장: ACST's revenue (26.1% per year) is forecast to grow faster than the Canadian market (5.5% per year).
고성장 수익: ACST's revenue (26.1% per year) is forecast to grow faster than 20% per year.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: Insufficient data to determine if ACST's Return on Equity is forecast to be high in 3 years time